Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FIBRINOGEN HUMAN for Drug therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where FIBRINOGEN HUMAN was used for Drug therapy.

Most Reported Side Effects for FIBRINOGEN HUMAN

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 40 9.8% 0 26
No adverse event 38 9.3% 3 9
Off label use 38 9.3% 7 10
Drug ineffective 34 8.3% 11 11
Hypotension 31 7.6% 0 4
Foetal anaemia 27 6.6% 0 27
Foetal growth restriction 27 6.6% 0 27
Haemorrhage in pregnancy 26 6.4% 0 26
Anaphylactic shock 25 6.1% 0 8
Maternal exposure during pregnancy 25 6.1% 0 16
Haemorrhage foetal 24 5.9% 0 24
Blood pressure increased 22 5.4% 0 1
Haemorrhage 21 5.2% 3 3
Hypertension 19 4.7% 1 2
Anaphylactic reaction 18 4.4% 0 1

Other Indications for FIBRINOGEN HUMAN

Product used for unknown indication (67) Hypofibrinogenaemia (41) Factor i deficiency (35) Haemorrhage (35) Congenital dysfibrinogenaemia (30) Postpartum haemorrhage (17) Procedural haemorrhage (17) Prophylaxis (16) Foetal exposure during pregnancy (11) Haemorrhage prophylaxis (11)

Other Drugs Used for Drug therapy

DENOSUMAB (364) RISPERIDONE (359) AMIODARONE (280) VASOPRESSIN (264) CABOTEGRAVIR (175) BISACODYL (151) ADALIMUMAB (133) DUPILUMAB (132) ETANERCEPT (108) CYCLOPHOSPHAMIDE (105)

Related Pages

FIBRINOGEN HUMAN Full Profile All Drug therapy Drugs FIBRINOGEN HUMAN Demographics FIBRINOGEN HUMAN Timeline